Why McKesson Stock Bumped Modestly Higher Today
Storied healthcare supplies company (NYSE: MCK) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. They liked, if not loved, what they saw, sending the shares to a 0.5% gain on that day. That was good enough to beat the S 500 index, which closed ever so slightly down by less than 0.1%.
After market hours Thursday, McKesson divulged that it earned revenue of $90.8 billion for the period, a meaty 19% improvement over the same quarter the previous year. It also managed to grow its non-GAAP (adjusted) net profit in the teen percentages, with the line item rising 15% to nearly $1.3 billion ($10.12 in per-share terms).
Image source: Getty Images.
Source Fool.com
McKesson Corp. Aktie
693,20 €
-0,03 %
Die McKesson Corp. Aktie ist ein klarer Community-Favorit: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Kursziel von 716 € für McKesson Corp. weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 693.2 € hin.
